References
- Hancock-Allen JB, Barker L, VanDyke M, et al. Notes from the field: death following ingestion of an edible marijuana product—Colorado, March 2014. MMWR Morb Mortal Wkly Rep. 2015;64:771–772.
- Andre C, et al. Delirium following ingestion of marijuana present in chocolate cookies. CNS Spectr. 2006;11:262–264.
- Pierre J, Gandal M, Son M. Canabis-induced psychosis associated with high potency “wax dabs”. Schizophr Res. 2016;172:211–212.
- Jouanjis E, Lapeyyre-Maestre M, Micallef J. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3:e000638.
- United Nations Publication. Recommended methods for the identification and analysis of cannabis and cannabis products. Vienna, Austria; United Nations Office on Drugs and Crime [Internet]; 2009 [cited 2016 Aug 17]. Available from: www.unodc.org/documents/scientific/ST-NAR-40-Ebook.pdf.
- Wolff V, Lauer V, Rouyer O, et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction a prospective study in 48 consecutive young patients. Stroke. 2011;42:1778–1780.
- ElSohly M, Zlatko M, Foster S, Gon C, et al. Changes in cannabis potency over the last 2 decades (1995–2014): analysis of current data in the United States. Biol Psychiatry. 2016;79:613–619.
- Hill M, Sun J, Tse M, et al. Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment. Int J Neuropsychopharm. 2006;9:277–286.
- Rodriguez de Fonseca F, Fernandez-Ruiz J, Murphy L, et al. Effects of delta-9-tetrahydrocannabinol exposure on adrenal medullary function: evidence of an acute effect and development of tolerance in chronic patients. Pharmacol Biochem Behav. 1991;40:593–598.
- Mechoulam R, Peters M, Murillo-Rodriquez E, et al. Cannabidiol-recent advances. Chem Biodivers. 2007;4:1678–1692.